PMDA — authorised 26 March 2019
- Marketing authorisation holder: FUJIMOTO PHARMACEUTICAL CORPORATION
- Status: approved
PMDA authorised Aselend on 26 March 2019
Yes. PMDA authorised it on 26 March 2019.
FUJIMOTO PHARMACEUTICAL CORPORATION holds the Japanese marketing authorisation.